<DOC>
	<DOCNO>NCT01429493</DOCNO>
	<brief_summary>In various common cancer , skeleton prefer site metastasis . These bone metastases common cause cancer-related pain , significantly impair quality life . It postulate clinical target volume ( CTV ) painful bone metastasis consist cancer cell tumor-associated host cell : tumor-host ecosystem . Advances biological imaging ( positron emit tomography PET ) might allow u selectively identify tumor-host ecosystem within anatomical boundary bone metastasis . These finding suggest potential intentionally non-homogenous dose escalation ( dose paint number ) improve pain control . The hypothesis fluorodeoxyglucose positron emit tomography ( FDG-PET ) detect intra-bone metastasis region confine tumor-associated host-cell compartment responsible metastasis-related pain . The primary objective improve pain control biological image-guided stereotactic body radiotherapy compare conventional radiotherapy .</brief_summary>
	<brief_title>Biological Image Guided Antalgic Stereotactic Body Radiotherapy Bone Metastases</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Diseases</mesh_term>
	<criteria>Painful bone metastasis solid tumor Pain score minimum 2 scale 10 A maximum number painful bone metastasis : 3 Life expectancy &gt; 3 month Age minimum 18 year old Signed informed consent Tumor histology ( renal cell melanoma vs. solid tumor ) VAS pain score ( &lt; 5 vs. 610 ) . Bisphosphonate use ( yes vs. ) Opioid analgesic ( yes vs. ) Corticosteroid use ( yes vs. ) Spine v nonspine localisation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>